Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
B-Complex Supplement for SANS in Astronauts
NCT05366933Phase 1Recruiting
- Sponsor
- NASA
- Start
- Aug 2022
- Primary completion
- Jul 2027
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial, sponsored by NASA. Primary endpoint: Optic Disc Edema at 6 months. Started Aug 2022; status: recruiting.
Beyond the preview
Go deeper on NCT05366933.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05366933.